FOLFIRI® and bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms.

BMC Res Notes · 2014 · PMC4022139 · PMID 24758527

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

Concerning the TYMS genotype, there was a linkage disequilibrium between the 3′UTR insdel variation and the 5′UTR tandem repeat, which was of borderline significance.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.